Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Chiesi expands rare disease universe

Why Chiesi launched strategic venture fund for rare diseases with Pappas

September 8, 2014 7:00 AM UTC

Chiesi Farmaceutici S.p.A. launched a strategic venture fund focused on rare and Orphan diseases - where the Italian pharma has been busily expanding - with an eye to building a global network of potential collaborators.

Chiesi is the major investor in Chiesi Ventures. A.M. Pappas & Associates will manage the fund and is the other investor...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article